| Mary Frances Kerr, MD | |
|
2004 Hayes St Ste 550, Nashville, TN 37203-2655 | |
| (629) 255-2223 | |
| (629) 255-4091 |
| Full Name | Mary Frances Kerr |
|---|---|
| Gender | Female |
| Speciality | Ophthalmology |
| Experience | 32 Years |
| Location | 2004 Hayes St Ste 550, Nashville, Tennessee |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083618680 | NPI | - | NPPES |
| Q024844 | Medicaid | TN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | MD27854 (Tennessee) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Heritage Medical Associates Pc | 4688651037 | 158 |
News Archive
Half of all stillbirths result from pregnancy disorders and conditions affecting the placenta, according to results reported by a National Institutes of Health research network established to find the causes of stillbirth as well as ways to prevent or reduce its occurrence.
Researchers at EPFL have built a matchbox-sized device that can test for the presence of bacteria in a couple of minutes, instead of up to several weeks. A nano-lever vibrates in the presence of bacterial activity, while a laser reads the vibration and translates it into an electrical signal that can be easily read-the absence of a signal signifies the absence of bacteria.
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering and developing breakthrough treatments for human disease, today announced that it has exercised a restructured purchase option under its drug development financing collaboration with Symphony Icon Holdings LLC and acquired all the equity of Symphony Icon, Inc., thereby reacquiring all rights to LX1031, LX1032, LX1033 and the other drug programs subject to the collaboration.
A new study led by researchers at Brigham and Women's Hospital has found that a single measurement of plasma glycated CD59 (GCD59), a novel biomarker for diabetes, at weeks 24-28 of gestation identified, with high sensitivity and specificity, women who failed the glucose challenge test as well as women with gestational diabetes.
One of every three children in Tennessee is overweight, and more than 20 percent of our children are obese. Childhood obesity has been linked to diabetes, high blood pressure, depression and poor academic performance.
› Verified 2 days ago
| Entity Name | Heritage Medical Associates Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548284060 PECOS PAC ID: 4688651037 Enrollment ID: O20040702000463 |
News Archive
Half of all stillbirths result from pregnancy disorders and conditions affecting the placenta, according to results reported by a National Institutes of Health research network established to find the causes of stillbirth as well as ways to prevent or reduce its occurrence.
Researchers at EPFL have built a matchbox-sized device that can test for the presence of bacteria in a couple of minutes, instead of up to several weeks. A nano-lever vibrates in the presence of bacterial activity, while a laser reads the vibration and translates it into an electrical signal that can be easily read-the absence of a signal signifies the absence of bacteria.
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering and developing breakthrough treatments for human disease, today announced that it has exercised a restructured purchase option under its drug development financing collaboration with Symphony Icon Holdings LLC and acquired all the equity of Symphony Icon, Inc., thereby reacquiring all rights to LX1031, LX1032, LX1033 and the other drug programs subject to the collaboration.
A new study led by researchers at Brigham and Women's Hospital has found that a single measurement of plasma glycated CD59 (GCD59), a novel biomarker for diabetes, at weeks 24-28 of gestation identified, with high sensitivity and specificity, women who failed the glucose challenge test as well as women with gestational diabetes.
One of every three children in Tennessee is overweight, and more than 20 percent of our children are obese. Childhood obesity has been linked to diabetes, high blood pressure, depression and poor academic performance.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mary Frances Kerr, MD 222 22nd Ave N, Nashville, TN 37203-1852 Ph: (629) 255-3486 | Mary Frances Kerr, MD 2004 Hayes St Ste 550, Nashville, TN 37203-2655 Ph: (629) 255-2223 |
News Archive
Half of all stillbirths result from pregnancy disorders and conditions affecting the placenta, according to results reported by a National Institutes of Health research network established to find the causes of stillbirth as well as ways to prevent or reduce its occurrence.
Researchers at EPFL have built a matchbox-sized device that can test for the presence of bacteria in a couple of minutes, instead of up to several weeks. A nano-lever vibrates in the presence of bacterial activity, while a laser reads the vibration and translates it into an electrical signal that can be easily read-the absence of a signal signifies the absence of bacteria.
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering and developing breakthrough treatments for human disease, today announced that it has exercised a restructured purchase option under its drug development financing collaboration with Symphony Icon Holdings LLC and acquired all the equity of Symphony Icon, Inc., thereby reacquiring all rights to LX1031, LX1032, LX1033 and the other drug programs subject to the collaboration.
A new study led by researchers at Brigham and Women's Hospital has found that a single measurement of plasma glycated CD59 (GCD59), a novel biomarker for diabetes, at weeks 24-28 of gestation identified, with high sensitivity and specificity, women who failed the glucose challenge test as well as women with gestational diabetes.
One of every three children in Tennessee is overweight, and more than 20 percent of our children are obese. Childhood obesity has been linked to diabetes, high blood pressure, depression and poor academic performance.
› Verified 2 days ago
Dr. Peter L Sonkin, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 345 23rd Ave N, Suite 350, Nashville, TN 37203 Phone: 615-983-6000 Fax: 615-983-6010 | |
Dr. Edward Chaum, MD PHD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 3601 The Vanderbilt Clinic, Nashville, TN 37232 Phone: 615-936-3000 | |
Dr. Mark R Melson, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 4306 Harding Pike, Suite 106, Nashville, TN 37205 Phone: 615-297-5798 Fax: 615-383-6646 | |
Dr. Everton L. Arrindell, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 345 - 23rd Avenue North, Suite 350, Nashville, TN 37203 Phone: 615-983-6000 Fax: 615-983-6010 | |
Dr. Christine Shieh, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 3601 The Vanderbilt Clinic, Nashville, TN 37232 Phone: 615-322-3000 | |
Lucas Lee Groves, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 3601 The Vanderbilt Clinic, Nashville, TN 37232 Phone: 615-322-3000 | |
Dr. Brigid K Marshall, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 345 23rd Ave N Ste 350, Nashville, TN 37203 Phone: 615-983-6000 Fax: 615-983-6010 |